康恩贝：董事长、法定代表人姜毅、董事蒋倩同日离任

Core Points - Jiang Yi, the chairman and legal representative of Kang En Bei Pharmaceutical Co., Ltd., submitted a resignation report to the board of directors due to work adjustment reasons [1] - Jiang Yi and Jiang Qian will no longer hold any positions in the company after their resignations [1] - Both Jiang Yi and Jiang Qian were originally scheduled to serve until August 15, 2027, and there are no unfulfilled public commitments from them [1]